PSEがオレフィン向け技術で炭化水素処理賞を獲得
ロンドン (ビジネスワイヤ) — 高度プロセスモデリング企業のプロセス・システムズ・エンタープライズ(PSE)は、新設された炭化水素処理自動化&モデリング最優秀賞(Hydrocarbon Processing Best Automation & Modeling...
View Article新研究调查Masimo氧储备指数™ ORi™的临床功效
瑞士纳沙泰尔 (美国商业资讯) — Masimo (NASDAQ: MASI)今天发布了最近在华盛顿特区召开的国际麻醉研究学会(IARS)年会上呈报的一篇摘要的结果。该研究中,加州大学戴维斯分校医学院的研究人员评估了Masimo氧储备指数™ (ORi™)作为危重患者动脉血红蛋白去氧饱和早期警报的潜在临床功效1。...
View ArticlePhase 1 Clinical Study Results of REMD Biotherapeutics’ Lead Product...
CAMARILLO, Calif. REMD Biotherapeutics, Inc. (“REMD Bio”), together with its subsidiary, Beijing-based Cosci-REMD Biotherapeutics (“Cosci-REMD Bio”), today announced data from a Phase 1 clinical...
View ArticleStarpharma Sells Agrochemicals Business to Agrium for $35M
MELBOURNE, Australia Starpharma Holdings Ltd (ASX: SPL, OTCQX: SPHRY) today announced that it has completed a transaction to sell its agrochemicals and Priostar® business (Starpharma Agrochemicals)...
View ArticleKieran Murphy受命接替John Flannery担任GE医疗集团首席执行官
波士顿 (美国商业资讯)–通用电气(GE)董事长兼首席执行官Jeff Immelt今日宣布,任命Kieran Murphy担任GE医疗集团总裁兼首席执行官,立即生效。Murphy目前担任GE医疗生命科学业务的总裁兼首席执行官,他将接替John Flannery,后者已被任命为通用电气公司继任首席执行官兼董事长。...
View ArticleCelltrion Healthcare showcases data supporting the efficacy and safety of...
INCHEON, South Korea New data presented at the International Conference on Malignant Lymphoma (ICML) and the European League Against Rheumatism (EULAR) congress 2017 demonstrate that CT-P10 is...
View ArticleACEA Biosciences Announces Successful Completion of Phase I Clinical Study of...
SAN DIEGO ACEA Biosciences today announced the completion of its Phase 1 clinical study of AC0058, a novel irreversible Bruton’s Tyrosine Kinase (BTK) inhibitor, which is in development for the...
View ArticlePimodivir Alone or in Combination with Oseltamivir Demonstrated a Significant...
SHANGHAI Janssen Pharmaceuticals, Inc. (Janssen) today announced results from the Phase 2b Topaz Trial which demonstrated that treatment with pimodivir (JNJ-63623872) significantly decreased viral...
View Articleマシモの予備酸素摂量指数(ORi™)の臨床的有用性を新しい研究で検討
スイス・ヌーシャテル (ビジネスワイヤ) — マシモ(NASDAQ: MASI)は本日、ワシントンD.C.で最近開催された国際麻酔学会(IARS)年次総会で報告されたアブストラクトの知見を発表しました。研究ではカリフォルニア大学デイビス校メディカルスクールの研究者らが、重症患者における動脈血ヘモグロビン飽和度低下の早期警報として、マシモの予備酸素摂量指数(Oxygen Reserve...
View ArticleHumacyte® Selected as 2017 Technology Pioneer by World Economic Forum
RESEARCH TRIANGLE PARK, N.C. Humacyte, an innovator in biotechnology and regenerative medicine, was selected among hundreds of candidates as one of the World Economic Forum’s 30 “Technology...
View ArticleIntensity Therapeutics Issued New Patents for Technology Platform
WESTPORT, Conn. Intensity Therapeutics, Inc., a privately held clinical-stage, biotechnology company developing proprietary cancer immunotherapy products, today announced that the United States...
View ArticleTransEnterix Announces Sale of Senhance™ Robotic Surgery System at Saitama...
RESEARCH TRIANGLE PARK, N.C. TransEnterix, Inc. (NYSE MKT:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that the...
View ArticleGI Dynamics Announces $5m Convertible Note Financing with Crystal Amber Fund
BOSTON & SYDNEY GI Dynamics® Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier® in Europe, the Middle East and South America for patients with type 2 diabetes and...
View Article苏尔寿混合技术有限公司起诉墨盒仿冒者并获得关键判决
瑞士哈格和上海 (美国商业资讯)–苏尔寿混合技术有限公司(Sulzer Mixpac Ltd.,以下简称“苏尔寿”)今天宣布,它已采取保护其产品在中国免遭仿冒的进一步法律行动。...
View ArticlePrestigious Nature Publication Highlights Novel PTEN Cancer Approach with...
MELBOURNE, Australia Clinical-stage oncology company Prescient Therapeutics Ltd (ASX:PTX; Prescient) announced that a pre-clinical study published in the scientific journal Nature this week...
View Articleメルク、がん個別化治療を推進するワールドワイド・イノベーティブ・ネットワーク(WIN)コンソーシアム(パリ)に加入
パリ & 独ダルムシュタット (ビジネスワイヤ) —...
View ArticleNew Study Compares Performance of Masimo Next Generation SedLine® Patient...
GENEVA Masimo (NASDAQ: MASI) announced today the findings of an abstract presented at Euroanaesthesia 2017 in Geneva, Switzerland. In the study, researchers at University Medical Center Groningen,...
View ArticleトランスエンテリックスがSenhance™ロボット手術システムを埼玉医科大学国際医療センターに販売したと発表
米ノースカロライナ州リサーチ・トライアングル・パーク (ビジネスワイヤ) — 低侵襲手術の改善を目的としたロボット工学の利用で草分けとなっている医療機器企業のトランスエンテリックス(NYSE MKT:TRXC)は本日、Senhanceロボット手術システムを大東京圏の埼玉県に位置する埼玉医科大学国際医療センターに販売したと発表しました。...
View Article